United Therapeutics Corporation is listed in the United States. Sector: Healthcare. Industry: Biotechnology.
United Therapeutics Corporation (UTHR): research close 584.10 USD on 2026-11-17. 52-week range 464.93 to 608.49 USD. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 584.10 USD | 2026-11-17 |
| Previous research close | 587.88 USD | 2026-11-16 |
| Change between the two dated research closes | -0.64% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 25.21 billion USD | 2026-11-16 |
| 52-week range of the research close | 464.93 – 608.49 USD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 23.77% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 307.28 million USD | 2026-11-17 |
Source: us_closes_adjusted · US · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save UTHR to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate